Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reverse Hybrid vs Concomitant Therapy for H. Pylori Eradication
NCT02646332Completed
- Sponsor
- Kaohsiung Veterans General Hospital
- Start
- Dec 2015
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dexlansoprazole, amoxicillin, clarithromycin and metronidazole in Helicobacter pylori infection (2 arms), sponsored by Kaohsiung Veterans General Hospital. Primary endpoint: Number of Participants in Which H. Pylori Was Eradicated. Started Dec 2015; status: completed.
02
Drugs
dexlansoprazoleamoxicillinclarithromycinmetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02646332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02646332.